1. Home
  2. ORN vs DVAX Comparison

ORN vs DVAX Comparison

Compare ORN & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORN
  • DVAX
  • Stock Information
  • Founded
  • ORN 1994
  • DVAX 1996
  • Country
  • ORN United States
  • DVAX United States
  • Employees
  • ORN N/A
  • DVAX N/A
  • Industry
  • ORN Military/Government/Technical
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORN Industrials
  • DVAX Health Care
  • Exchange
  • ORN Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • ORN 339.4M
  • DVAX 1.3B
  • IPO Year
  • ORN 2007
  • DVAX 2004
  • Fundamental
  • Price
  • ORN $7.56
  • DVAX $9.26
  • Analyst Decision
  • ORN Strong Buy
  • DVAX Buy
  • Analyst Count
  • ORN 2
  • DVAX 4
  • Target Price
  • ORN $11.25
  • DVAX $26.50
  • AVG Volume (30 Days)
  • ORN 339.4K
  • DVAX 1.9M
  • Earning Date
  • ORN 10-29-2025
  • DVAX 11-06-2025
  • Dividend Yield
  • ORN N/A
  • DVAX N/A
  • EPS Growth
  • ORN N/A
  • DVAX N/A
  • EPS
  • ORN 0.27
  • DVAX N/A
  • Revenue
  • ORN $837,494,000.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • ORN $4.83
  • DVAX $23.23
  • Revenue Next Year
  • ORN $8.34
  • DVAX $16.57
  • P/E Ratio
  • ORN $27.45
  • DVAX N/A
  • Revenue Growth
  • ORN 15.85
  • DVAX 26.66
  • 52 Week Low
  • ORN $4.64
  • DVAX $9.22
  • 52 Week High
  • ORN $9.95
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • ORN 53.08
  • DVAX 31.66
  • Support Level
  • ORN $7.18
  • DVAX $9.51
  • Resistance Level
  • ORN $7.71
  • DVAX $9.94
  • Average True Range (ATR)
  • ORN 0.29
  • DVAX 0.29
  • MACD
  • ORN 0.08
  • DVAX -0.08
  • Stochastic Oscillator
  • ORN 81.93
  • DVAX 4.23

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: